Page 35 - CIBERES2016-ENG

• Line SAHS & NO INVASIVE VENTILATION (NIV): Develop new ways of simplified diagnosis, deepen treatment indications and establish new indications for NIV outside the critical care units. Investigate the causes of failure of NIV and asynchrony.
• Line RESEARCH IN LUNG TRANSPLANTATION: Advance knowledge of the causes of rejection and infection and diagnosis, and expand the selection criteria organ donor and recipient.
Most relevant scientific articles
• Delcroix M., Lang I., Pepke-Zaba J., Jansa P., D’Armini A.M., Snijder R. et al. Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension: Results from an International Prospective Registry. Circulation. 2016;133(9):859-871.
• Hartl S., Lopez-Campos J.L., Pozo-Rodriguez F., Castro-Acosta A., Studnicka M., Kaiser B. et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. European Respiratory Journal. 2016;47(1):113-121.
• Masa J.F., Corral J., Caballero C., Barrot E., Teran-Santos J., Alonso-alvarez M.L. et al. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax. 2016.
• Eberhardt W.E.E., Mitchell A., Rami-Porta R.Reply to the letter to the editor by Hendriks et al.Journal of Thoracic Oncology. 2016;11(3): e43-e44.
• Goldstraw P., Chansky K., Crowley J., Rami-Porta R., Asamura H., Eberhardt W.E.E. et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer. Journal of Thoracic Oncology. 2016;11(1):39-51.
Highlights
All research lines of Group 21 continue their scientific activity. Highlights from this work are:
• Coordination Pulmonary Circulation Group of the European Society of Cardiology
• The International prospective registry of Chronic thromboembolic pulmonary hypertension (CTEPH)
colaboration
• Presidency of the International Statistical Committee at IASLC
• Strengthening of a Spanish hospital network of research in EPOC that fulfills 10 years of joint and
continuous work.
• Consolidation of clinical audit of histories as a standardized tool for the collection of clinical
information in network research studies
• Active participation in the pathologists panel of the CIBERES Strategic Cancer Project for the evaluation
of clinical and molecular biomarkers in early lung cancer.
RES
research groups 35